FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3128996963> ?p ?o ?g. }

• W3128996963 endingPage "101027" @default.
• W3128996963 startingPage "101027" @default.
• W3128996963 abstract "To describe a case of ischemic retinal vasculitis in Adamantiades-Behçet disease (ABD) that demonstrated significant resolution of retinal ischemia following treatment with nicotinic acid and infliximab.Observations: A 12-year-old male with a history of recurrent oral ulcers, fevers, and failure to thrive was admitted to the hospital with fever, oral and perirectal mucositis, and poor oral intake one month before presentation to uveitis clinic. He was suspected to have ABD and was treated with three doses of intravenous (IV) methylprednisolone (30 mg/kg/day) which led to improvement in his systemic symptoms. One week after admission, he complained of decreased vision in both eyes (OU), during which he was found to have anterior uveitis in OU and was referred to the Uveitis Clinic. Upon examination, his visual acuity was 20/80 in OU. Intraocular pressures were within normal limits. Anterior chamber evaluation revealed 0.5+ cells and 1.5+ flare in OU. Posterior examination revealed pale optic nerve, sclerosis and vascular sheathing of retinal arteries, and collateral vessels in OU. Fluorescein angiography (FA) showed optic disc leakage and widespread retinal ischemia in OU. The patient was diagnosed with retinal occlusive vasculitis associated with ABD. He was initially treated with infliximab (5 mg/kg), systemic methylprednisolone, and mycophenolate mofetil. Three months later, his BCVA improved to 20/70 OU with slight improvement of retinal ischemia on FA. Nicotinic acid was added to his treatment regimen. Due to logistic challenges, he did not receive infliximab treatment during the subsequent three months. However, three months after beginning nicotinic acid therapy, FA revealed significant improvement of his retinal ischemia OU. Conclusion: To our knowledge, the index report is the first to show that nicotinic acid may improve retinal ischemia in vaso-occlusive retinal vasculitis and be an integral part of the treatment regimen of this sight-threatening condition." @default.
• W3128996963 created "2021-02-15" @default.
• W3128996963 creator A5003596747 @default.
• W3128996963 creator A5023260226 @default.
• W3128996963 creator A5031043376 @default.
• W3128996963 creator A5031108408 @default.
• W3128996963 creator A5039464724 @default.
• W3128996963 creator A5048251212 @default.
• W3128996963 creator A5050191788 @default.
• W3128996963 creator A5061977147 @default.
• W3128996963 creator A5081939949 @default.
• W3128996963 creator A5091022089 @default.
• W3128996963 date "2021-03-01" @default.
• W3128996963 modified "2023-09-30" @default.
• W3128996963 title "Reperfusion of retinal ischemia in retinal occlusive vasculitis with nicotinic acid and infliximab in Adamantiades-Behçet's disease" @default.
• W3128996963 cites W1972240373 @default.
• W3128996963 cites W1977947414 @default.
• W3128996963 cites W1979874662 @default.
• W3128996963 cites W1984733295 @default.
• W3128996963 cites W1985788023 @default.
• W3128996963 cites W1989262657 @default.
• W3128996963 cites W2025521578 @default.
• W3128996963 cites W2043198160 @default.
• W3128996963 cites W2047941689 @default.
• W3128996963 cites W2050309460 @default.
• W3128996963 cites W2055814753 @default.
• W3128996963 cites W2060721487 @default.
• W3128996963 cites W2065990347 @default.
• W3128996963 cites W2068130629 @default.
• W3128996963 cites W2115572248 @default.
• W3128996963 cites W2119328183 @default.
• W3128996963 cites W2123687373 @default.
• W3128996963 cites W2123752743 @default.
• W3128996963 cites W2133388984 @default.
• W3128996963 cites W2137444863 @default.
• W3128996963 cites W2141091492 @default.
• W3128996963 cites W2144337820 @default.
• W3128996963 cites W2157593633 @default.
• W3128996963 cites W2170420181 @default.
• W3128996963 cites W2172010318 @default.
• W3128996963 cites W2402886937 @default.
• W3128996963 cites W2533344666 @default.
• W3128996963 cites W2562594314 @default.
• W3128996963 cites W2585774436 @default.
• W3128996963 cites W2616282150 @default.
• W3128996963 cites W2725187802 @default.
• W3128996963 cites W2790404215 @default.
• W3128996963 cites W2790599478 @default.
• W3128996963 cites W2796372149 @default.
• W3128996963 cites W2811395636 @default.
• W3128996963 cites W2927231191 @default.
• W3128996963 cites W2947161633 @default.
• W3128996963 cites W2963993754 @default.
• W3128996963 cites W4238750038 @default.
• W3128996963 cites W4253299102 @default.
• W3128996963 cites W938949745 @default.
• W3128996963 doi "https://doi.org/10.1016/j.ajoc.2021.101027" @default.
• W3128996963 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7878990" @default.
• W3128996963 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33615039" @default.
• W3128996963 hasPublicationYear "2021" @default.
• W3128996963 type Work @default.
• W3128996963 sameAs 3128996963 @default.
• W3128996963 citedByCount "7" @default.
• W3128996963 countsByYear W31289969632021 @default.
• W3128996963 countsByYear W31289969632022 @default.
• W3128996963 countsByYear W31289969632023 @default.
• W3128996963 crossrefType "journal-article" @default.
• W3128996963 hasAuthorship W3128996963A5003596747 @default.
• W3128996963 hasAuthorship W3128996963A5023260226 @default.
• W3128996963 hasAuthorship W3128996963A5031043376 @default.
• W3128996963 hasAuthorship W3128996963A5031108408 @default.
• W3128996963 hasAuthorship W3128996963A5039464724 @default.
• W3128996963 hasAuthorship W3128996963A5048251212 @default.
• W3128996963 hasAuthorship W3128996963A5050191788 @default.
• W3128996963 hasAuthorship W3128996963A5061977147 @default.
• W3128996963 hasAuthorship W3128996963A5081939949 @default.
• W3128996963 hasAuthorship W3128996963A5091022089 @default.
• W3128996963 hasBestOaLocation W31289969631 @default.
• W3128996963 hasConcept C118487528 @default.
• W3128996963 hasConcept C126322002 @default.
• W3128996963 hasConcept C141071460 @default.
• W3128996963 hasConcept C2776015282 @default.
• W3128996963 hasConcept C2777138892 @default.
• W3128996963 hasConcept C2778328719 @default.
• W3128996963 hasConcept C2779134260 @default.
• W3128996963 hasConcept C2780372218 @default.
• W3128996963 hasConcept C2780827179 @default.
• W3128996963 hasConcept C71924100 @default.
• W3128996963 hasConceptScore W3128996963C118487528 @default.
• W3128996963 hasConceptScore W3128996963C126322002 @default.
• W3128996963 hasConceptScore W3128996963C141071460 @default.
• W3128996963 hasConceptScore W3128996963C2776015282 @default.
• W3128996963 hasConceptScore W3128996963C2777138892 @default.
• W3128996963 hasConceptScore W3128996963C2778328719 @default.
• W3128996963 hasConceptScore W3128996963C2779134260 @default.
• W3128996963 hasConceptScore W3128996963C2780372218 @default.
• W3128996963 hasConceptScore W3128996963C2780827179 @default.
• W3128996963 hasConceptScore W3128996963C71924100 @default.

• next